CLA Does Not Impair Endothelial Function and Decreases Body Weight as Compared with Safflower Oil in Overweight and Obese Male Subjects

Journal of the American College of Nutrition

Volumn 30, Issue 1, 2011, Pages 19-28

  Pfeuffer, Maria ^a   Fielitz, Kerstin ^a,b   Laue, Christiane ^b   Winkler, Petra ^b   Rubin, Diana ^a,b   Helwig, Ulf ^a   Giller, Katrin ^a   Kammann, Julia ^a   Schwedhelm, Edzard ^c   Böger, Rainer H ^c   Bub, Achim ^a   Bell, Doris ^d   Schrezenmeir, Jürgen ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

Cardiovascular disease; Endothelial function; Metabolic syndrome; PAT index

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 8 ISOPROSTAGLANDIN F2 ALPHA; ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; CHOLESTEROL; CONJUGATED LINOLEIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; SAFFLOWER OIL; SUCROSE; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTERY; ARTICLE; BODY MASS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENDOTHELIAL FUNCTION; ENZYME ACTIVITY; FAT INTAKE; HEATING; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PERIPHERAL ARTERIAL TONOMETRY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SUGAR INTAKE; TONOMETRY; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

AGED; BIOLOGICAL MARKERS; CARBOXYLIC ESTER HYDROLASES; CARDIOVASCULAR DISEASES; DINOPROST; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; F2-ISOPROSTANES; FASTING; HUMANS; LINOLEIC ACIDS, CONJUGATED; MALE; MANOMETRY; MIDDLE AGED; OBESITY; OVERWEIGHT; PHYTOTHERAPY; POSTPRANDIAL PERIOD; RISK FACTORS; SAFFLOWER OIL; WEIGHT LOSS;

ANIMALIA; CARTHAMUS TINCTORIUS;

EID: 79960361669     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2011.10719940     Document Type: Article

References (61)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005.
2. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction (review). Clin Sci (Lond) 109:143-159, 2005.
3. Esposito K, Marfella R, Ciotola M, Di Palo C, Giugliano F, Giugliano G, D'Armiento M, D'Andrea F, Giugliano D: Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292:1440-1446, 2004.
4. Bonetti PO, Lerman LO, Lerman A: Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168-175, 2003.
5. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G: Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17:789-810, 2006.
6. Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP: Conjugated linoleic acid impairs endothelial function. Arterioscler Thromb Vasc Biol 26:307-312, 2006.
7. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM: Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr 80:887-895, 2004.
8. Risérus U, Vessby B, Arnlöv J, Basu S: Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men. Am J Clin Nutr 80:279-283, 2004.
9. Risérus U, Arner P, Brismar K, Vessby B: Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25:1516-1521, 2002.
10. Risérus U, Basu S, Jovinge S, Fredrikson GN, Arnlöv J, Vessby B: Supplementation with conjugated linoleic acid causes isomerdependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106:1925-1929, 2002.
11. Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B: Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr 94:791-795, 2005.
12. Ruano J, Lopez-Miranda J, Fuentes F, Moreno JA, Bellido C, Perez-Martinez P, Lozano A, Gomez P, Jimenez Y, Perez Jimenez F: Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients. J Am Coll Cardiol 46:1864-1868, 2005.
13. Visioli F, Caruso D, Grande S, Bosisio R, Villa M, Galli G, Sirtori C, Galli C: Virgin Olive Oil Study (VOLOS): vasoprotective potential of extra virgin olive oil in mildly dyslipidemic patients. Eur J Nutr 44:121-127, 2005.
14. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, De Caterina R: Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler Thromb Vasc Biol 23:622-629, 2003.
15. Sies H, Stahl W, Sevanian A: Nutritional, dietary and postprandial oxidative stress. J Nutr 135:969-972, 2005.
16. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros R, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Circulation 106:1211-1218, 2002.
17. Rubin D, Helwig U, Nothnagel M, Fölsch UR, Schreiber S, Schrezenmeir J: Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel. Eur J Endocrinol 162:719-727, 2010
18. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE: Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146:168-174, 2003.
19. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, Mitchell GF, Sheffy J, Vita JA, Benjamin EJ: Crosssectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117:2467-2474, 2008.
20. Tsikas D, Schwedhelm E, Suchy MT, Niemann J, Gutzki FM, Erpenbeck VJ, Hohlfeld JM, Surdacki A, Frö lich JC: Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha): possible methodological, mechanistic and clinical implications. J Chromatogr B Analyt Technol Biomed Life Sci 794:237-255, 2003.
21. Aarsman AJ, Neys FW, van den Bosch H: Catabolism of plateletactivating factor and its acyl analog. Eur J Biochem 200:187-193, 1991.
22. Gan KN, Smolen A, Eckerson HW, La Du BN: Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos 19:100-106, 1991.
23. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN: Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57-60, 1998.
24. Raff M, Tholstrup T, Sejrsen K, Straarup EM, Wiinberg N: Diets rich in conjugated linoleic acid and vaccenic acid have no effect on blood pressure and isobaric arterial elasticity in healthy young men. J Nutr 136:992-997, 2006.
25. Sluijs I, Plantinga Y, de Roos B, Mennen LI, Bots ML: Dietary supplementation with cis-9, trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults. Am J Clin Nutr 91:175-183, 2010.
26. Westphal S, Taneva E, Kästner S, Martens-Lobenhoffer J, Bode-Böger S, Kropf S, Dierkes J, Luley C: Endothelial dysfunction induced by postprandial lipemia is neutralized by addition of proteins to the fatty meal. Atherosclerosis 185:313-319, 2006.
27. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, Paolisso G, Marfella R, Giugliano D: Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 39:1145-1150, 2002.
28. Herrera JA, Arevalo-Herrera M, Shahabuddin AK, Ersheng G, Herrera S, Garcia RG, Lopez-Jaramillo P: Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypertens 19:381-387, 2006.
29. Inoue N, Nagao K, Hirata J, Wang YM, Yanagita T: Conjugated linoleic acid prevents the development of essential hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun 323:679-684, 2004.
30. Whigham LD, Watras AC, Schoeller DA: Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 85:1203-1211, 2007.
31. Nazare JA, de la Perrière AB, Bonnet F, Desage M, Peyrat J, Maitrepierre C, Louche-Pelissier C, Bruzeau J, Goudable J, Lassel T, Vidal H, Laville M: Daily intake of conjugated linoleic acidenriched yoghurts: effects on energy metabolism and adipose tissue gene expression in healthy subjects. Br J Nutr 97:273-280, 2007.
32. Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA: The role of conjugated linoleic 22 acid in reducing body fat and preventing holiday weight gain. Int J Obes (Lond) 31:481-487, 2007.
33. Racine NM, Watras AC, Carrel AL, Allen DB, McVean JJ, Clark RR, O'Brien AR, O'Shea M, Scott CE, Schoeller DA: Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr 91:1157-1164, 2010.
34. Thom E, Wadstein J, Gudmundsen O: Conjugated linoleic acid reduces body fat in healthy exercising humans. J Int Med Res 29:392-396, 2001.
35. Bhattacharya A, Rahman MM, Sun D, Lawrence R, Mejia W, McCarter R, O'Shea M, Fernandes G: The combination of dietary conjugated linoleic acid and treadmill exercise lowers gain in body fat mass and enhances lean body mass in high fat-fed male Balb/C mice. J Nutr 135:1124-1130, 2005.
36. Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O: Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. Br J Nutr 97:550-560, 2007.
37. Lambert EV, Goedecke JH, Bluett K, Heggie K, Claassen A, Rae DE, West S, Dugas J, Dugas L, Meltzeri S, Charlton K, Mohede I: Conjugated linoleic acid versus high-oleic acid sunflower oil: effects on energy metabolism, glucose tolerance, blood lipids, appetite and body composition in regularly exercising individuals. Br J Nutr 97:1001-1011, 2007.
38. Song HJ, Grant I, Rotondo D, Mohede I, Sattar N, Heys SD, Wahle KW: Effect of CLA supplementation on immune function in young healthy volunteers. Eur J Clin Nutr 59:508-517, 2005.
39. Changhua L, Jindong Y, Defa L, Lidan Z, Shiyan Q, Jianjun X: Conjugated linoleic acid attenuates the production and gene expression of proinflammatory cytokines in weaned pigs challenged with lipopolysaccharide. J Nutr 135:239-244, 2005.
40. Turpeinen AM, Ylönen N, von Willebrand E, Basu S, Aro A: Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Br J Nutr 100:112-119, 2008.
41. Benito P, Nelson GJ, Kelley DS, Bartolini G, Schmidt PC, Simon V: The effect of conjugated linoleic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 36:221-227, 2001.
42. Basu S, Smedman A, Vessby B: Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 468:33-36, 2000.
43. Parra P, Serra F, Palou A: Moderate doses of conjugated linoleic acid isomers mix contribute to lowering body fat content maintaining insulin sensitivity and a noninflammatory pattern in adipose tissue in mice. J Nutr Biochem 21:107-115, 2010.
44. Herrmann J, Rubin D, Häsler R, Helwig U, Pfeuffer M, Auinger A, Laue C, Winkler P, Bell D, Schreiber S, Schrezenmeir J: Isomerspecific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism. Lipids Health Dis 8:35, 2009.
45. Aviram M, Rosenblat M: Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304-1316, 2004.
46. Nguyen SD, Sok DE: Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position. Biochim Biophys Acta 1758:499-508, 2006.
47. Rosenblat M, Gaidukov L, Khersonsky O, Vaya J, Oren R, Tawfik DS, Aviram M: The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 281:7657-7665, 2006.
48. Su ND, Liu XW, Kim MR, Jeong TS, Sok DE: Protective action of CLA against oxidative inactivation of paraoxonase 1, an antioxidant enzyme. Lipids 38:615-622, 2003.
49. Valeille K, Ferezou J, Amsler G, Quignard-Boulange A, Parquet M, Gripois D, Dorovska-Taran V, Martin JC: A cis-9, trans-11-conjugated linoleic acid-rich oil reduces the outcome of atherogenic process in hyperlipidemic hamster. Am J Physiol Heart Circ Physiol 289:H652-H659, 2005.
50. Thomàs-Moyà E, Gianotti M, Proenza AM, Lladó I: The agerelated paraoxonase 1 response is altered by long-term caloric restriction in male and female rats. J Lipid Res 47:2042-2048, 2006.
51. Rantala M, Silaste ML, Tuominen A, Kaikkonen J, Salonen JT, Alfthan G, Aro A, Kesäniemi YA: Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. J Nutr 132:3012-3017, 2002.
52. Fraley AE, Tsimikas S: Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease. Curr Opin Lipidol 17:502-509, 2006.
53. Couillard C, Ruel G, Archer WR, Pomerleau S, Bergeron J, Couture P, Lamarche B, Bergeron N: Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. J Clin Endocrinol Metab 90:6454-6459, 2005.
54. Sjogren P, Basu S, Rosell M, Silveira A, de Faire U, Vessby B, Hamsten A, Hellenius ML, Fisher RM: Measures of oxidized lowdensity lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome. Arterioscler Thromb Vasc Biol 25:2580-2586, 2005.
55. Morrow JD, Roberts LJ: The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36:1-21, 1997.
56. Cracowski JL, Ormezzano O: Isoprostanes, emerging biomarkers and potential mediators in cardiovascular diseases. Eur Heart J 25:1675-1678, 2004.
57. Meagher EA, FitzGerald GA: Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28:1745-1750, 2000.
58. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA: Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol 20:2248-2254, 2000.
59. Kom GD, Schwedhelm E, Maas R, Schneider L, Benndorf R, Böger RH: Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients. Br J Clin Pharmacol 63:672-679, 2007.
60. Iannone A, Petroni A, Murru E, Cordeddu L, Carta G, Melis MP, Bergamini S, Casa LD, Cappiello L, Carissimi R, O'Shea M, Bell D, De Santis E, Banni S: Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA). Prostaglandins Leukot Essent Fatty Acids 80:279-287, 2009.
61. Tsikas D, Schwedhelm E, Fauler J, Gutzki FM, Mayatepek E, Frö lich JC: Specific and rapid quantification of 8-iso-prostaglandin F2a in urine of healthy humans and patients with Zellweger syndrome by gas chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 716:7-17, 1998.